Position in QURE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,016,917
+$6,082,793 QoQ
Shares Held
152,343
+166.6% QoQ
Ownership
0.242%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 255 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in QURE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,060,262,064 across 202 Biotechnology names. QURE ranks #81 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in QURE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,016,917 | 152,343 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $934,124 | 57,133 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,694,148 | 70,796 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $9,277,502 | 158,943 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $10,621,554 | 761,948 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,827,138 | 549,730 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $9,392,117 | 531,830 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,268,383 | 865,798 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,812,792 | 851,070 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,689,062 | 709,435 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $5,553,160 | 820,260 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,512,659 | 374,465 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,621,083 | 403,236 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $8,847,481 | 439,299 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $10,321,220 | 455,281 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $9,476,894 | 505,165 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,933,182 | 479,248 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $8,811,275 | 487,619 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,237,720 | 156,110 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $16,069,051 | 502,001 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,911,242 | 224,391 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $7,587,997 | 225,230 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $14,389,782 | 398,278 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $4,845,353 | 131,560 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $5,949,902 | 132,044 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,820,152 | 80,509 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||